Clinical Trial Update: Mucuna Pruriens Therapy in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Mucuna Pruriens extract therapy for Parkinson's disease has completed. The update confirms the trial status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Mucuna Pruriens therapy (Mucuna pruriens extract)

Snippet

Sponsor: ASST Gaetano Pini-CTO | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED